Results 291 to 300 of about 20,906,376 (325)
Some of the next articles are maybe not open access.
Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C
Current Medical Research and Opinion, 2004To evaluate the efficacy of high and moderate doses of simvastatin (80 and 40 mg), for raising high density lipoprotein-cholesterol (HDL-C), improving HDL sub-fractions, and affecting other parameters, including high sensitivity C-reactive protein (hs-CRP), in patients with type 2 diabetes mellitus (DM) and low HDL-C.This double-blind, placebo ...
Michael, Miller +5 more
openaire +2 more sources
New Drugs for HDL-C Disorders: The Beginning
Current Medicinal Chemistry, 2014For more than 20 years there has been increasing interest in the development of novel therapies to raise levels of high-density lipoprotein cholesterol (HDL-C). However, well publicized failures of recent clinical trials of agents that raise HDL-C levels have stimulated considerable controversy with regard to the potential clinical utility of this ...
Duong, M., Nicholls, S.
openaire +3 more sources
HDL-C: Role as a risk modifier
Atherosclerosis Supplements, 2011Evidence that low-density lipoprotein-cholesterol (LDL-C) causes cardiovascular disease (CVD) is overwhelming. It has also been proven beyond all doubt that lowering the level of LDL-C using statins reduces CV risk. However, many people remain at high risk even when their level of LDL-C has been reduced by aggressive treatment with statins.
openaire +2 more sources
Biomarkers in Medicine, 2023
Aim: The study sought to investigate the association of non-high-density-lipoprotein cholesterol-to-high-density-lipoprotein cholesterol ratio (NON-HDL-C:HDL-C) with coronary lesions and major adverse cardiovascular events (MACE) in first-onset non-ST-segment elevation acute myocardial infarction.
Qi Mao, Jianhua Zhao, Xiaohui Zhao
openaire +2 more sources
Aim: The study sought to investigate the association of non-high-density-lipoprotein cholesterol-to-high-density-lipoprotein cholesterol ratio (NON-HDL-C:HDL-C) with coronary lesions and major adverse cardiovascular events (MACE) in first-onset non-ST-segment elevation acute myocardial infarction.
Qi Mao, Jianhua Zhao, Xiaohui Zhao
openaire +2 more sources
Climacteric, 2019
Background: A novel lipid relation, the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio gathers information on all atherogenic and antiatherogenic particles on a single date. The relationship between this lipid marker and the presence of carotid atherosclerotic plaque (CAP) in postmenopausal ...
W, Masson +5 more
openaire +2 more sources
Background: A novel lipid relation, the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio gathers information on all atherogenic and antiatherogenic particles on a single date. The relationship between this lipid marker and the presence of carotid atherosclerotic plaque (CAP) in postmenopausal ...
W, Masson +5 more
openaire +2 more sources
Different association of HDL-C, apoA-I, and HDL-C/apoA-I with multiple outcomes in HFrEF patients
International Journal of CardiologyHigh-density lipoprotein-cholesterol (HDL-C) has been considered a cardioprotective factor for several decades. However, its association with outcomes in patients with heart failure with reduced ejection fraction (HFrEF) remains controversial. We aimed to investigate the association of HDL-C, apolipoprotein A-I (apoA-I), and the HDL-C/apoA-I ratio with
Ayiguli, Abudukeremu +13 more
openaire +2 more sources
Postgraduate Medicine, 2005
Although statin therapy has revolutionized management of coronary heart disease (CHD), the lowering of low-density lipoprotein cholesterol (LDL-C) levels is not the whole story. Increased plasma concentrations of high-density lipoprotein cholesterol (HDL-C) have a cardioprotective effect that is just as important for reducing risk of heart attack and ...
openaire +2 more sources
Although statin therapy has revolutionized management of coronary heart disease (CHD), the lowering of low-density lipoprotein cholesterol (LDL-C) levels is not the whole story. Increased plasma concentrations of high-density lipoprotein cholesterol (HDL-C) have a cardioprotective effect that is just as important for reducing risk of heart attack and ...
openaire +2 more sources
THE ACUTE EFFECTS OF EXERCISE AT DIFFERENT INTENSITIES ON HDL-C AND HDL-C SUDFRACTIONS
Medicine & Science in Sports & Exercise, 1992P. M. Gordon +6 more
openaire +1 more source
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
Circulation, 2021Alan Remaley +2 more
exaly
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
Circulation Research, 2023Tao Huan +2 more
exaly